September 2004

All Stories

Poor colon cancer screening rates

in Uncategorized | 2 responses

Colon cancer screening rates are still low:

Overall, 58 percent of men and 51 percent of women [aged 50 to 74 years -ed] in the study reported ever having undergone endoscopy, but only 35 percent reported being tested in the five years before 1997. Just 42 percent of men and 31 percent of women reported endoscopy for screening (rather than for disease diagnosis or follow-up).
It is recommended by most ...

Vioxx FAQ

in Uncategorized | no responses

A nice summary of frequently asked questions to the Vioxx recall from WebMD, including more information on the trial:

What evidence supports the withdrawal?

Merck's decision to withdraw Vioxx from the market is based on new data from a trial called the APPROVe trial. In the APPROVe trial, Vioxx was compared with placebo (sugar pill). The purpose of the trial was to see if the 25 mg dose ...

Pfizer responds

in Uncategorized | no responses

Pfizer stands by its drug in response to the Vioxx recall, calling Celebrex is an "appropriate treatment alternative," to Vioxx. Too soon to say whether this is a class effect, but certainly Celebrex and Bextra will be closely watched.

Vioxx fallout: Lawsuit boon?

in Uncategorized | no responses

James Cramer with a view from TheStreet.com - Merck Will Be Tort Bar's Next Target:

Is Merck going to be a trust for those who took Vioxx? That's what you are betting if you sell this stock down $12. You are betting that the tort bar, which has almost finished destroying tobacco and asbestos, just found its newest target.

Frankly, I think that's a decent bet. I fear ...

Vioxx fallout

in Uncategorized | no responses

Now that Vioxx has been pulled from the market, what to do? My office has certainly been deluged with calls. From what I can gather, the study leading to the recall showed an increased risk of heart attack and other CV complications 18 months after patients took 25mg of Vioxx. Here are some options to ponder if you are on Vioxx:

1) Switch to Celebrex at ...

Merck withdraws Vioxx

in Uncategorized | one response

Following up this previously written piece, today Merck pulls Vioxx from the market. Huge news - and what does the future hold for other COX-2's, like Celebrex and Bextra?

Update:
Here is a link to the study leading to the withdrawal. Some key points:
1) There was an over 3-fold risk of acute MI and sudden cardiac death for those taking over 25mg of Vioxx.

Debate on malpractice

in Uncategorized | no responses

There is an interesting debate going on at Medrants between Dr. Centor and a lawyer. The topic of defensive medicine came up:

Many physicians do order unnecessary tests. This phenomenon occurs most often in emergency rooms, but also occurs in office practice.

When does this occur? I do not have hard data (again db asks for help from the readers), but I believe that I see ...

Increasing revenue

in Uncategorized | no responses

Pharmacies are thinking about charging for consultations:

Pharmacists like White have long been called on by customers to do more than just fill prescriptions. But drugstores, from giants like Rite Aid to smaller regional chains, are looking to expand their counseling programs and boost revenue - a trend that could be bolstered by the prescription-drug benefit that will become available to Medicare enrollees in 2006.

Malpractice affecting the people

in Uncategorized | no responses

Think the malpractice crisis isn't affecting the public? Think again:

The IssuesPA/Pew Poll has found that a remarkable 26 percent of Pennsylvanians polled "said rising malpractice insurance costs have forced their family to change doctors in the past year", and that state residents polled also favored a constitutional cap on pain and suffering damages by a margin of 68 percent to 24 percent.

Neurologists debate . . .

in Uncategorized | no responses

. . . the growing trend of cosmetic neurology. One scenario:

"For instance, if pilots perform better in emergencies when they take donepezil (a drug typically used to treat dementia), should they be expected or required by their employer to take this medication?" Chatterjee said. "We need an explicit notion of what it means to be human and a clear sense of the evolving role of physicians."

Arms race

in Uncategorized | no responses

Massachusetts has the same number of MRIs as all of Canada, and there are no signs of slowing down:

Not surprising, the number of patients having MRIs is soaring, too; 487,700 scans in 2002, up more than 80 percent in four years, according to the most recent data from IMV Medical Information Division, an Illinois market-research company. Nationally, spending on diagnostic imaging is projected to grow to as much ...

Empowerment

in Uncategorized | one response

This article suggests that the price-comparison tool on the Medicare web site will have Medicare beneficiaries questioning their doctors about their prescriptions:

The discovery that a competing brand-name drug or generic substitute is significantly less costly will likely convince some beneficiaries to ask their physicians about the appropriateness of a switch, Health and Human Services Secretary Tommy Thompson said at a briefing.

"Nobody compares prices better than ...

Battle-lines . . .

in Uncategorized | no responses

. . . are drawing closer. Not only in Florida, but also in three other states:

Rivaling Bush vs. Kerry for bitterness, doctors and trial lawyers are squaring off this fall in an unprecedented four-state struggle over limiting malpractice awards. The volatile issue is in voters' hands and each side is desperate to win, spending millions of dollars to make their cases and portray the other side as ...

Use of myoglobin for cardiac injury

in Uncategorized | 2 responses

Studies are continuing to quickly and accurately diagnose chest pain in the ER. I was recently having a discussion where the topic of serum myoglobin came up as a routine part of the cardiac enzyme panel at some institutions.

The hospitals that I work at typically only include the CK, CK-MB and troponin I as markers for cardiac injury - I was less ...

Another point for tort reform

in Uncategorized | no responses

More black and white. Tort reform works (from PointofLaw):

The Medical Assurance Co. of Mississippi, which provides medical malpractice insurance to about 60 percent of the doctors in the state, will not raise base premium rates in 2005.

Insurance Commissioner [and Democrat] George Dale said Friday that the decision shows that "those people who said that tort reform would not work and actively fought any civil ...

Page 1 of 512345

Kevin Pho, MD

See all in: Pho

Physician

See all in: Physician

Patient

See all in: Patient

Policy

See all in: Policy

Tech

See all in: Tech

Social Media

See all in: Social media